Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase I clinical trial commences in Germany for insomnia compound

Feb. 2, 1999

NeuroSearch commences phase II clinical trials of potential antidepressant

Feb. 2, 1999

Vanguard Medica and Elan seek regulatory approval of Miguard in the U.S.

Feb. 2, 1999

AMPA receptor antagonists in the pipeline at Schering

Feb. 2, 1999

Neurobiological Technologies awarded SBIR grant for Xerecept development

Feb. 1, 1999

European Commission approves Betaseron for treatment of SPMS

Jan. 29, 1999

Antipsychotic development candidate selected from carbazolone series by Spanish scientists

Jan. 29, 1999

Neotrofin shows positive results in phase II trial for Alzheimer's disease

Jan. 29, 1999

Angiotech to study paclitaxel for yet another new indication

Jan. 28, 1999

OP-1 protects against cerebral infarct in rat model

Jan. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...